Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated With Imatinib Mesylate With Different BCR-ABL Transcripts Levels Response. MLU 2021, 21 (1), 949-955. https://doi.org/10.37506/mlu.v21i1.2438.